MDR1 inhibition increases sensitivity to doxorubicin and etoposide in adrenocortical cancer

Research output: Contribution to journalArticleAcademicpeer-review

6 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)367-378
Number of pages12
JournalEndocrine-Related Cancer
Volume26
Issue number3
DOIs
Publication statusPublished - 2019

Cite this